Blastic mantle cell leukemia: An unusual presentation of blastic mantle cell lymphoma

Modern Pathology

Volumn 13, Issue 7, 2000, Pages 825-833

  Viswanatha, David S ^a,c   Foucar, Kathryn ^a   Berry, Brian R ^b   Gascoyne, Randy D ^b   Evans, H Lance ^a   Leith, Catherine P ^a  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c Department of Pathology   (United States)

Author keywords

Acute lymphoblastic leukemia; BCL 1 gene; Mantle cell lymphoma leukemia; Mature B cell leukemia

Indexed keywords

CD34 ANTIGEN; CD5 ANTIGEN; CYCLIN D1; PROTEIN BCL 2;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B CELL LEUKEMIA; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; MALE; MANTLE CELL LYMPHOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

EID: 0033910535     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3880144     Document Type: Article

References (46)

1. Hammami A, Chan WC, Michels SD, Nassar VH. Mature B cell acute leukemia: a clinical, morphological, immunological and cytogenetic study of nine cases. Hematol Pathol 1991;5:109-18.
2. Molot RJ, Meeker TC, Wittwer CT, Perkins SL, Segal GH, Masih AS, et al. Antigen expression and polymerase chain reaction amplification of mantle cell lymphomas. Blood 1994;83:1626-31.
3. Segal GH, Masih AS, Canavan Fox A, Jorgensen T, Scott M, Braylan RC. CD5-expressing B cell non-Hodgkin's lymphomas with bcl-1 gene rearrangement have a relatively homogeneous immunophenotype and are associated with an overall poor prognosis. Blood 1995;85:1570-9.
4. Williams ME, Meeker TC, Swerdlow SH. Rearrangement of the chromosome 11 bcl-1 locus in centrocytic lymphoma: analysis with multiple breakpoint probes. Blood 1991;78: 493-8.
5. Williams ME, Swerdlow SH, Rosenberg CL, Arnold A. Chromosome 11 translocation breakpoints at the Prad1/cyclin d1 gene locus in centrocytic lymphoma. Leukemia 1993;7:241-5.
6. Pinyol M, Campo E, Nadal A, Terol JM, Jares P, Nayach Irazema, et al. Detection of the bcl-1 rearrangement at the major translocation cluster in frozen and paraffin-embedded tissues of mantle cell lymphomas by polymerase chain reaction. Am J Clin Pathol 1996;105:532-7.
7. Vasef MA, Brynes RK, Murata-Collins JL, Arber DA, Medeiros LJ. Surface immunoglobulin light chain-positive acute lymphoblastic leukemia of FAB L1 or L2 type: a report of 6 cases in adults. Am J Clin Pathol 1998;110:143-9.
8. Asou N, Osata M, Horikawa K, Nishikawa K, Sakitani O, Li L, et al. Burkitt's type acute lymphoblastic transformation associated with t(8;14) in a case of B cell chronic lymphocytic leukemia. Leukemia 1997;11:1986-8.
9. Litz CE, Arthur DC, Gajl-Peczalska KJ, Rausch D, Copenhaver C, Coad JE, et al. Transformation of chronic lymphocytic leukemia to small non-cleaved cell lymphoma: a cytogenetic, immunological and molecular study. Leukemia 1991;5:972-8.
10. Mohamed AN, Compean R, Dan ME, Smith MR, Al-Katib A. Clonal evolution of chronic lymphocytic leukemia to acute lymphoblastic leukemia. Cancer Genet Cytogenet 1996;86: 143-6.
11. Dunphy CH, Wheaton SE, Perkins SL. CD23 expression in transformed small lymphocytic lymphomas/chronic lymphocytic leukemias and blastic transformations of mantle cell lymphoma. Mod Pathol 1997;10:818-22.
12. Brito-Babapulle V, Ellis J, Matutes E, Oscier D, Khokhar T, MacLennan K, et al. Translocalion t(11;14)(q13;q32) in chronic lymphoid disorders. Genes Chromosomes Cancer 1992;5:158-65.
13. Cohen PL, Kurtin PJ, Donovan KA, Hanson CA. Bone marrow and peripheral blood involvement in mantle cell lymphoma. Br J Haematol 1998;101:302-10.
14. Campo E, Raffeld M, Jaffe ES. Mantle cell lymphoma. Semin Hematol 1999;36:115-27.
15. Weisenburger DD, Armitage JO. Mantle cell lymphoma: an entity comes of age. Blood 1996;87:4483-94.
16. Argatoff LH, Connors JM, Klasa RJ, Horsman DE, Gascoyne RD. Mantle cell lymphoma: a clinicopathologic study of 80 cases. Blood 1997;89:2067-78.
17. Samaha H, Dumontet C, Ketterer N, Moullett I, Thieblemont C, Bouafia F, et al. Mantle cell lymphoma: a retrospective study of 121 cases. Leukemia 1998;12:1281-7.
18. Rimokh R, Berger F, Delsol G, Charrin C, Bertheas MF, Ffrench M, et al. Rearrangement and overexpression of the BCL-1/PRAD-1 gene in intermediate lymphocytic lymphomas and in t(11q13)-bearing leukemias. Blood 1993;81:3063-7.
19. Oka K, Ohno T, Kita K, Yamaguchi M, Takakura N, Nishii K, et al. PRAD1 gene overexpression in mantle cell lymphoma but not in other low grade B-cell lymphomas, including extranodal lymphoma. Br J Haematol 1994;86:786-91.
20. Bosch F, Jares P, Campo E, Lopez-Guillermo A, Piris MA, Villamor N, et al. PRAD1/cyclin d1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. Blood 1994;84:2726-32.
21. de Boer CJ, van Krieken JM, Schuuring E, Kluin PM. Bd-1/ cyclin D1 in malignant lymphoma. Annu Oncol 1997;8(Suppl 2):S109-17.
22. Lardelli P, Bookman MA, Sundeen J, Longo DL, Jaffe ES. Lymphocytic lymphoma of intermediate differentiation: morphologic and immunophenotypic spectrum and clinical correlations. Am J Surg Pathol 1990;14:752-63.
23. Ott MM, Ott G, Kuse R, Porowski P, Gunzer U, Feller AC, et al. The anaplastic variant of centrocytic lymphoma is marked by frequent rearrangements of the bcl-1 gene and high proliferation indices. Histopathology 1994;24:329-34.
24. Zoldan MC, Inghirami G, Masuda Y, Vandekerckhove F, Raphael B, Amorosi E, et al. Large cell variants of mantle cell lymphoma: cytologic characteristics and p53 anomalies may predict poor outcome. Br J Haematol 1996;93:475-86.
25. Pittaluga S, Verhoef G, Criel A, Criel A, Maes AM, Nuyts JM, et al. Prognostic significance of bone marrow trephine and peripheral blood smears in 55 patients with mantle cell lymphoma. Leuk Lymphoma 1996;21:115-25.
26. Shivdasani RA, Hess JL, Skarin AT, Pinkus GS. Intermediate lymphocytic lymphoma: clinical and pathologic features of a recently characterized subtype of non-Hodgkin's lymphoma. J Clin Oncol 1993;11:802-11.
27. Pombo de Oliveira MS, Jaffe ES, Catovsky D. Leukaemic phase of mantle zone (intermediate) lymphoma: its characterisation in 11 cases. J Clin Pathol 1989;42:962-72.
28. Vadlamudi G, Lionetti KA, Greenberg S, Mehta K. Leukemic phase of mantle cell lymphoma. Two case reports and review of the literature. Arch Pathol Lab Med 1996;120:35-40.
29. Cuneo A, Balboni M, Piva N, Rigolin GM, Roberti MG, Mejak C, et al. Atypical chronic lymphocytic leukemia with t(11; 14)(q13;q32): karyotype evolution and prolymphocytic transformation. Br J Haematol 1995;90:409-16.
30. Daniel MT, Tigaud I, Flexor MA, Nogueira ME, Berger R, Jonveaux P. Leukaemic non-Hodgkin's lymphomas with hyperdiploid cells and t(11;14)(q13;q32): a subtype of mantle cell lymphoma? Br J Haematol 1995;90:77-84.
31. Singleton TP, Anderson MM, Ross CW, Schnitzer B. Leukemic phase of mantle cell lymphoma, blastoid variant. Am J Clin Pathol 1999;111:495-500.
32. Leroux D, Le Marc'Hadour F, Gressin R, Jacob MC, Keddari E, Monteil M, et al. Non-Hodgkin's lymphomas with t(11; 14)(q13;q32): a subset of mantle zone/intermediate lymphocytic lymphoma? Br J Haematol 1991;77:346-53.
33. Tirier C, Zhang Y, Plendl H, Weber-Matthiesen K, Langer W, Schlegerlberger B. Simultaneous presence of t(11;14) and a variant Burkitt's translocation in the terminal phase of a mantle cell lymphoma. Leukemia 1996;10:346-50.
34. Monteil M, Callanan M, Dascalescu C, Sotto JJ, Leroux D. Molecular diagnosis of t(11;14) in mantle cell lymphoma using two-colour interphase fluorescence in situ hybridization. Br J Haematol 1996;93:656-60.
35. Coignet LJA, Schuuring E, Kibbelaar RE, Raap TK, Kleiverda KK, Bertheas MF, et al. Detection of 11q13 rearrangements in hematologic neoplasias by double-colour fluorescence in situ hybridization. Blood 1996;87:1512-9.
36. Vaandrager JW, Shuuring E, Zwikstra E, de Boer CJ, Kleiverda KK, Han J, et al. Direct visualization of dispersed 11q13 chromosomal translocations in mantle cell lymphoma by multicolor DNA fiber fluorescence in situ hybridization. Blood 1996;88:1177-82.
37. Yang WI, Zukerberg LR, Motokura T, Arnold A, Harris NL. Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. Am J Pathol 1994;145:86-96.
38. Zukerberg LR, Yang WI, Arnold A, Harris NL. Cyclin D1 expression in non-Hodgkin's lymphomas: detection by immunohistochemistry. Am J Clin Pathol 1995;103:756-60.
39. de Boer CJ, Schuuring E, Dreef E, Peters G, Bartek J, Kluin PM, et al. Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma. Blood 1995;86:2715-23.
40. Alkan S, Schnitzer B, Thompson JL, Moscinski LC, Ross CW. Cyclin D1 protein expression in mantle cell lymphoma. Ann Oncol 1995;6:567-70.
41. Ott MM, Bartkova J, Bartek J, Durr A, Fischer L, Ott G, et al. Cyclin D1 expression in mantle cell lymphoma is accompanied by downregulation of cyclin D3 and is not related to proliferative activity. Blood 1997;90:3154-9.
42. Vasef MA, Medeiros LJ, Koo C, McCourty A, Brynes RK. Cyclin D1 Immunohistochemical staining is useful in distinguishing mantle cell lymphoma from other low-grade B-cell neoplasms in bone marrow. Am J Clin Pathol 1997;108: 302-7.
43. Soslow RA, Zukerberg LR, Harris NL, Warnke RA. BCL-1 (PRAD1/cyclin D1) overexpression distinguishes the blastoid variant of mantle cell lymphoma from B-lineage lymphoblastic lymphoma. Mod Pathol 1997;10:810-7.
44. Mauvieux L, Canioni D, Hermine O, Valensi F, Radford-Weiss I, Azagury M, et al. Quantitative RNA slot-blot analysis of CCND1/cyclin D1 expression in suspected mantle cell lymphoma. Leukemia 1998;12:78-85.
45. Uchimaru K, Taniguchi T, Yoshikawa M, Asano S, Arnold A, Fujita T, et al. Detection of cyclin D1 (bcl-1, PRAD1) over-expression by a simple competitive reverse transcription-polymerase chain reaction assay in t(11;14)(q13;q32)-bearing B cell malignancies and/or mantle cell lymphoma. Blood 1997;89:965-74.
46. Levy V, Ugo V, Delmer A, Tang R, Ramond S, Perrot JY, et al. Cyclin D1 overexpression allows identification of an aggressive subset of leukemic lymphoproliferative disorder. Leukemia 1999;13:1343-51.